Hologic, Inc. Stock
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 07-01 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| 05-26 | Hologic and Biotheranostics Present New Data on Breast Cancer Index Test At Asco 2026 | CI |
| Market Cap | 16.97B 14.9B 13.86B 12.72B 23.9B 1,634B 24.27B 165B 64.3B 803B 63.7B 62.33B 2,778B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 15.27B 14.2B 13.03B 24.49B 1,675B 24.87B 169B 65.9B 823B 65.28B 63.87B 2,847B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +1.28% | ||
| Current year | +2.04% |
| Current year | 74.49 | 76.07 | |
| 1 year | 63.19 | 76.07 | |
| 3 years | 51.9 | 84.67 | |
| 5 years | 51.9 | 87.88 | |
| 10 years | 26.49 | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 07/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 16/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 07/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/4/26 | Issuer sale | Director | 56,632 | 0.0254% | ||
| 7/4/26 | Issuer sale | Executive/Senior Manager | 123,246 | 0.0552% | ||
| 7/4/26 | Issuer sale | Director | 65,866 | 0.0295% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.48% | -.--% | +14.99% | -6.53% | 16.97B | ||
| -0.71% | +6.72% | +19.63% | -0.57% | 211B | ||
| -0.52% | -6.05% | -5.58% | -25.77% | 135B | ||
| +1.65% | -2.29% | -30.93% | +4.31% | 119B | ||
| +1.54% | +0.50% | -58.34% | -15.18% | 65.77B | ||
| -1.42% | -3.62% | +9.01% | -9.60% | 47.58B | ||
| +3.03% | -0.17% | -26.81% | -31.58% | 44.44B | ||
| -0.84% | +5.41% | +15.14% | +8.50% | 39.14B | ||
| -2.02% | +1.54% | +25.53% | +30.56% | 36.79B | ||
| -1.41% | +3.99% | +80.31% | +3.20% | 29.37B | ||
| Average | -0.02% | +0.49% | +4.30% | -4.27% | 74.51B | |
| Weighted average by Cap. | +0.01% | +0.37% | -1.00% | -6.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.54B 3.29B 3.02B 5.68B 388B 5.76B 39.09B 15.27B 191B 15.13B 14.8B 660B | 4.1B 3.6B 3.35B 3.07B 5.77B 395B 5.86B 39.77B 15.54B 194B 15.39B 15.06B 671B |
| Net income | 790M 693M 645M 592M 1.11B 76.03B 1.13B 7.66B 2.99B 37.38B 2.96B 2.9B 129B | 566M 497M 462M 424M 797M 54.48B 809M 5.49B 2.14B 26.78B 2.12B 2.08B 92.6B |
| Net Debt | 321M 282M 262M 241M 452M 30.94B 459M 3.12B 1.22B 15.21B 1.21B 1.18B 52.6B | 421M 370M 344M 315M 593M 40.53B 602M 4.08B 1.59B 19.93B 1.58B 1.55B 68.9B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions


















